Pot Stock Cronos Higher After Upgrade By Investing.com

Investing.com – Cannabis stock Cronos Group rose in midday trade on Wednesday after Bank of America/Merrill Lynch upgraded it to buy from underperform.

Analysts Christopher Carey cited the prospect of the Canadian-based company expanding into the U.S. market as the reason for the upgrade.

Cronos CEO Mike Gorenstein told Wall Street analysts on Tuesday that the company plans to be aggressive on its CBD launch in the U.S., prompting Carey to increase his rating, Bloomberg reported.

Carey noted in a research note that Cronos’ partnership with Altria Group (NYSE:) is the key to the U.S. and he sees the potential of Cronos leveraging Altria’s distribution as what will distinguish it from other cannabis brands.

Cronos (NASDAQ:) jumped 7.5%, while Tilray (NASDAQ:) fell 1.6% and Canopy Growth (NYSE:) was down 1.8%. Aurora Cannabis (NYSE:) slumped 3.5%.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.